{
  "schema_version": "pdp_json_v1",
  "peptide": {
    "canonical_name": "Ghk Cu",
    "short_name": "GHK-Cu",
    "aliases": [
      "GHK-Cu",
      "Copper peptide GHK-Cu",
      "Glycyl-L-histidyl-L-lysine copper complex",
      "GHK copper complex"
    ],
    "classification": {
      "category": "investigational_human",
      "needs_prescription": false,
      "notes": "Primarily used as a topical cosmetic ingredient. Not an FDA-approved therapeutic drug; outcomes depend heavily on formulation and delivery."
    },
    "status": {
      "category": "investigational_human",
      "jurisdiction": "GLOBAL",
      "last_reviewed": "2026-01-17",
      "human_use_note": "Copper Tripeptide-1 (GHK-Cu) is widely used topically in skincare. Human evidence is mixed and formulation-dependent. It is not an FDA-approved therapeutic drug."
    },
    "structure": {
      "sequence_oneletter": "",
      "amino_acid_seq": "Gly-His-Lys (copper complex)",
      "molecular_formula": "",
      "molecular_weight": null,
      "structure_image_url": ""
    },
    "risk": {
      "current_score": 2,
      "severity": "mild",
      "likelihood": "unlikely",
      "evidence_grade": "human_interventional",
      "developmental_risk": true,
      "unknowns_penalty": true,
      "rationale": "Topical cosmetic use generally presents low systemic risk. Main uncertainty comes from variable formulations, inconsistent objective outcomes across small human studies, and limited standardized long-term safety characterization across product types.",
      "risk_score": 2
    },
    "sections": {
      "overview": [
        {
          "claim_type": "overview",
          "title": "What it is",
          "population_group": "general",
          "confidence": "moderate",
          "evidence_grade": "human_interventional",
          "text": "Copper Tripeptide-1 (GHK-Cu) is a copper-binding peptide complex used in topical products for skin appearance and barrier-related goals. Evidence includes small human studies and broader reviews; results may depend on formulation and delivery to target layers.",
          "evidence_refs": [
            "E1",
            "E2",
            "E3"
          ]
        }
      ],
      "use_cases": [],
      "mechanism": [],
      "human_effects": [],
      "preclinical_effects": [],
      "hypothesized_effects": [],
      "time_dynamics": [],
      "risks": [],
      "contraindications": [],
      "monitoring": [],
      "observed_exposure_ranges": [
        {
          "route": "topical",
          "unit": "formulation-dependent",
          "min": null,
          "max": null,
          "frequency": "varies",
          "duration": "varies",
          "population_group": "general",
          "notes": "Descriptive only. Products vary widely by formulation and concentration. Not instructions.",
          "evidence_refs": [
            "E1",
            "E2",
            "E3"
          ]
        }
      ],
      "developmental_risk_block": [
        {
          "claim_type": "risk",
          "population_group": "adolescent",
          "confidence": "unknown",
          "evidence_grade": "mechanistic_only",
          "text": "Developmental exposure may carry higher and less predictable risk than adult exposure. Long-term effects on growth, endocrine signaling, and neurodevelopment are not well studied and may be irreversible.",
          "evidence_refs": []
        }
      ],
      "interaction_summary": [],
      "current_outlook_bullets": [
        "copper Tripeptide-1 (GHK-Cu) is a copper-binding peptide complex used in topical products for skin appearance and barrier-related goals",
        "evidence includes small human studies and broader reviews; results may depend on formulation and delivery to target layers",
        "skin appearance and texture support",
        "interest in skin remodeling pathways",
        "general recovery and resilience interest (anecdotal)",
        "common biohacker curiosity due to community reports",
        "interest in mechanisms suggested by early evidence",
        "used in goal-based stacking discussions (anecdotal)",
        "exploration in wellness communities despite evidence limits"
      ]
    },
    "evidence": [
      {
        "id": "E1",
        "title": "Regenerative and Protective Actions of the GHK-Cu Peptide in the Skin",
        "source_type": "pmc",
        "source_id": "PMC6073405",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/",
        "published_date": "2018-01-01",
        "evidence_grade": "human_observational",
        "notes": "Review covering skin-related evidence and mechanisms; mixes human, preclinical, and mechanistic data.",
        "year": 2018
      },
      {
        "id": "E2",
        "title": "Human skin penetration of a copper tripeptide in vitro as a function of skin layer and delivery conditions",
        "source_type": "pmc",
        "source_id": "PMC3016279",
        "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3016279/",
        "published_date": "2010-01-01",
        "evidence_grade": "in_vitro",
        "notes": "Penetration/delivery study relevant to topical delivery variability.",
        "year": 2010
      },
      {
        "id": "E3",
        "title": "Effects of topical copper tripeptide complex on photoaged skin (clinical cosmetic study)",
        "source_type": "doi",
        "source_id": "10.1001/archfaci.8.4.252",
        "url": "https://www.liebertpub.com/abs/doi/10.1001/archfaci.8.4.252",
        "published_date": "2006-01-01",
        "evidence_grade": "human_interventional",
        "notes": "Clinical cosmetic study; objective wrinkle/skin-quality outcomes may be mixed; patient-reported satisfaction may differ from measured changes."
      }
    ],
    "changelog": [
      {
        "date": "2026-01-17",
        "change_type": "initial_entry",
        "summary": "Initial canonical entry for Copper Tripeptide-1 (GHK-Cu)",
        "detail": "Added topical cosmetic peptide entry with review + delivery evidence + clinical cosmetic study reference; low-risk topical profile with uncertainty penalty due to formulation variability.",
        "evidence_refs": [
          "E1",
          "E2",
          "E3"
        ]
      }
    ],
    "meta": {
      "appears_in_blends": [
        "glow",
        "klow"
      ]
    },
    "topics": {
      "primary": [
        "topic_skin_cosmetic"
      ]
    },
    "slug": "ghk-cu"
  },
  "canonical_name": "Ghk Cu",
  "interactions": {
    "drug_classes": [
      "anticoagulants-antiplatelets",
      "nsaids",
      "immunosuppressants",
      "biologics-immunomodulators"
    ],
    "supplement_classes": [],
    "peptides": []
  }
}
